Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 18.3B | 18.4B | 18.3B | 17.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.6B | 1.5B | 1.5B | 1.5B |
Other operating expenses | 161M | 253M | 183M | 171M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 258M | 259M | 257M | 257M |
Other income expense | 76M | 85M | 94M | 80M |
Pretax income | 1.4B | 1.4B | 2.0B | 1.2B |
Tax provision | 404M | 106M | 653M | 249M |
Net income | 950M | 1.3B | 1.3B | 953M |
Basic EPS | 1.3 | 1.8 | 1.8 | 1.3 |
Diluted EPS | 1.3 | 1.8 | 1.8 | 1.3 |
Basic average shares | 764.4M | 779.8M | 783.4M | 796.0M |
Diluted average shares | 769.7M | 781.9M | 788.4M | 800.7M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -5M | -4M | 1M | -7M |
Preferred stock dividends | — | — | — | — |